• Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact
Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer
  • Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact

Archives

Monthly Archive for: "November, 2019"
 HUMAN ANTIBODIES & HYBRIDOMAS 2020
 0
By Nascent Biotech
In Science News
Posted November 25, 2019

HUMAN ANTIBODIES & HYBRIDOMAS 2020

Nascent Biotech founder Dr. Mark C. Glassy will once again be organizing and speaking at the Human Antibodies & Hybridomas conference, held 11-13 November 2020, The Richard Doll Building, [...]

READ MORE
 Recent Publications from Nascent Biotech Founder Dr. Mark C. Glassy
 0
By Nascent Biotech
In Science News
Posted November 4, 2019

Recent Publications from Nascent Biotech Founder Dr. Mark C. Glassy

Click each link to download individual publications in PDF format. Brain‐derived neurotrophic factor downregulation in gastric cancer Antibody drug conjugates: Progress, pitfalls, and promises [...]

READ MORE
© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.